Gene delivery using a derivative of the protein transduction domain peptide, K-Antp.

Due to their intracellular permeability, protein transduction domains (PTDs) have been widely used to deliver proteins and peptides to mammalian cells. However, their performance in gene delivery has been relatively poor. To improve the efficiency of PTD-mediated gene delivery, we synthesized a new peptide, KALA-Antp (K-Antp), which contains the sequences for PTD of the third alpha-helix of Antennapedia (Antp) homeodomain and the fusogenic peptide KALA. In this configuration, Antp is designed to provide the cell permeation capacity and nuclear localization signal, while the KALA moiety to promote cellular entry of the peptide-DNA complex. An optimal K-Antp/DNA formula was nearly 400-600 fold more efficient than Antp or poly-lysine-Antp (L-Antp) in gene delivery, and comparable or superior to a commercial liposome. The K-Antp-mediated plasmid DNA transfection not only exhibited temperature sensitivity, reflecting the involvement of an endocytosis-mediated gene transfer mechanism similar to other known PTDs, but also temperature insensitivity, suggesting the role of an energy-independent mechanism. Incorporation of an endosomolytic polymer polyethylenimine (PEI) into the system or treatment with chloroquine further increased the efficiency of K-Antp-mediated gene delivery. These results demonstrate the potential of the combinatorial use of KALA, Antp and PEI in the development of efficient PTD-derived gene carriers.

[1]  Y. Yeom,et al.  Receptor-mediated gene transfer to cells of hepatic origin by galactosylated albumin-polylysine complexes. , 1999, Biological & pharmaceutical bulletin.

[2]  R. Murphy,et al.  Effect of Bafilomycin A1 and Nocodazole on Endocytic Transport in HeLa Cells: Implications for Viral Uncoating and Infection , 1998, Journal of Virology.

[3]  Do Young Yoon,et al.  A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA , 2006, The journal of gene medicine.

[4]  W. Hennink,et al.  The Nuclear Pore Complex: The Gateway to Successful Nonviral Gene Delivery , 2006, Pharmaceutical Research.

[5]  P. Berggren,et al.  Identification of a nuclear localization signal, RRMKWKK, in the homeodomain transcription factor PDX‐1 , 1999, FEBS letters.

[6]  Vladimir P Torchilin,et al.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Gunnar P. H. Dietz,et al.  Delivery of bioactive molecules into the cell: the Trojan horse approach , 2004, Molecular and Cellular Neuroscience.

[8]  H. Boulaiz,et al.  Non-viral and viral vectors for gene therapy. , 2005, Cellular and molecular biology.

[9]  L. Young,et al.  Viral gene therapy strategies: from basic science to clinical application , 2006, The Journal of pathology.

[10]  F. Szoka,et al.  GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. , 2004, Advanced drug delivery reviews.

[11]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Chaloin,et al.  Translocating peptides and proteins and their use for gene delivery. , 2000, Current opinion in biotechnology.

[13]  T. Park,et al.  A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Kwang Dong Kim,et al.  Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  W. Sessa,et al.  Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo , 2003, Nature Medicine.

[16]  E. Vivés,et al.  TAT peptide internalization: seeking the mechanism of entry. , 2003, Current protein & peptide science.

[17]  H. Inokuchi,et al.  Protein Transduction Domain of HIV-1 Tat Protein Promotes Efficient Delivery of DNA into Mammalian Cells* , 2001, The Journal of Biological Chemistry.

[18]  A. Prochiantz,et al.  Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.

[19]  W. Sessa,et al.  Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo , 2003, Nature Medicine.

[20]  F. Szoka,et al.  Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. , 1997, Biochemistry.

[21]  M. Manns,et al.  Protein Transduction Domains Fused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors , 2004, Journal of Virology.

[22]  J. Swanson,et al.  Different fates of phagocytosed particles after delivery into macrophage lysosomes , 1996, The Journal of cell biology.

[23]  Priscille Brodin,et al.  A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.

[24]  W. Seeger,et al.  Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[25]  D. Porteous,et al.  HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[26]  M. Ogris,et al.  Melittin Enables Efficient Vesicular Escape and Enhanced Nuclear Access of Nonviral Gene Delivery Vectors* , 2001, The Journal of Biological Chemistry.

[27]  M. Feltkamp,et al.  Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor. , 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[28]  H. Dosaka-akita,et al.  Fusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool , 2004, British Journal of Cancer.

[29]  Richard N Cohen,et al.  Quantification of plasmid DNA copies in the nucleus after lipoplex and polyplex transfection. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Vladimir P Torchilin,et al.  Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. , 2005, Advanced drug delivery reviews.

[31]  Y. Okahata,et al.  Optimization of nuclear localization signal for nuclear transport of DNA-encapsulating particles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.